Nurix Therapeutics NRIX Growth Metrics (2019-2026)

NASDAQ NRIX
$26.15 +0.05 (+0.17%)
As of: Oct 21, 2026 · 11:41 AM EDT
Reported Financials

Nurix Therapeutics Quarterly Growth Metrics

Periods 27 quarters
Latest May 2026

Nurix Therapeutics reported revenue growth of -79.47% and asset growth of -9.47% for the quarter ended May 2026. These growth metrics cover 27 quarters of results from Nov 2019 through May 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026
Growth Ratios
Assets Growth (1y)
19.71%20.29%10.35%-23.88%-6.84%-12.59%-15.44%-11.08%-32.90%-14.68%-15.53%45.75%66.65%88.23%96.70%15.76%1.73%2.81%3.43%-9.47%
Assets Growth (3y)
111.50%-9.21%-3.55%-7.62%-0.45%1.37%11.97%12.00%14.48%4.39%18.19%19.78%15.16%
Assets Growth (5y)
72.32%4.87%11.67%9.91%0.67%
Assets (QoQ)
-4.81%-3.31%-8.19%-9.92%16.49%-9.27%-11.18%-5.28%-12.10%15.38%-12.07%63.44%0.50%30.32%-8.11%-3.82%-11.68%31.71%-7.56%-15.81%
Capital Expenditures Growth (1y)Capex Growth (1y)
11.68%-4.86%311.86%33.38%83.27%197.56%-34.42%-61.28%-28.06%0.78%26.66%79.35%-4.55%-18.57%20.84%38.10%15.51%143.75%-70.01%-27.63%
Capital Expenditures Growth (3y)Capex Growth (3y)
39.10%84.26%-12.52%13.77%41.83%50.68%-2.52%7.96%34.66%0.12%-1.38%-7.43%26.00%-22.87%21.48%
Capital Expenditures Growth (5y)Capex Growth (5y)
17.17%57.12%10.65%10.17%41.45%4.39%-1.53%
Capital Expenditures (QoQ)Capex (QoQ)
-10.81%-53.78%302.78%-19.67%22.55%-24.96%-11.23%-52.57%127.69%5.12%11.57%-32.84%21.17%-10.31%65.56%-23.24%1.35%89.27%-79.63%85.26%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-44.47%-32.55%-37.66%-77.93%-67.75%-19.91%-57.39%41.95%-11.04%-15.27%48.38%98.09%134.12%101.36%52.40%-27.85%-20.80%124.52%-6.22%-19.67%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-2.84%22.80%-45.79%-22.94%-26.68%-14.71%-12.42%10.96%-1.23%26.59%18.15%56.46%28.48%4.71%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
13.82%25.87%-21.64%15.65%-10.84%-18.50%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-21.66%-45.40%-2.14%-47.28%14.50%35.57%-47.93%75.62%-28.25%29.13%-8.81%134.46%-15.19%11.06%-30.98%10.99%-6.91%214.85%-71.17%-4.93%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
88.68%70.68%1,777.04%91.66%-415.71%250.61%-59.86%1,019.85%136.11%-126.13%121.02%-399.03%-193.69%-879.73%-28.10%154.55%336.54%100.25%-584.96%30.07%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
144.42%41.40%174.85%30.27%51.32%156.51%-31.91%-20.38%-56.81%-13.92%157.15%40.95%-81.54%-113.31%28.50%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-100.32%27.08%100.75%19.79%14.90%-120.29%29.40%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
78.58%-198.61%209.60%-111.90%-1,223.74%187.21%-70.79%172.78%-48.04%-163.11%347.08%-469.08%83.72%-559.90%118.13%180.03%-29.40%-99.31%-35,887.86%175.10%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-388.06%-50.92%-629.37%-4.37%-54.50%-22.79%-13.66%43.89%11.18%170.32%13.42%-114.98%-2.54%-282.66%-45.62%-59.08%-36.06%-39.14%-17.72%-52.90%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-43.86%-47.09%-8.58%-88.50%48.93%-93.18%-7.98%-12.06%-16.40%-12.74%-24.27%-7.41%-21.35%-14.07%-73.57%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-30.77%-28.41%-34.35%-56.36%-27.06%-61.33%-25.09%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
4.96%-3.13%-37.91%22.79%-40.69%18.04%-27.66%61.88%-122.71%164.88%-257.18%5.35%-6.23%-15.59%-25.30%-3.40%9.14%-18.21%-6.02%-34.29%
EBITDA Margin Growth (1y)
0.02M-0.02M0.00M0.00M-0.01M-0.02M0.01M0.03M0.02M0.04M0.01M-0.03M-0.02M-0.02M-0.01M0.03M-0.07M-0.01M-0.11M-0.09M
EBITDA Margin Growth (3y)
-0.04M255.000.01M0.02M0.02M289.000.02M0.00M-0.01M0.00M0.01M0.03M-0.07M0.01M-0.11M-0.09M
EBITDA Margin Growth (5y)
-0.04M0.02M0.01M0.02M-0.07M-0.03M-0.10M-0.07M
EBITDA Margin (QoQ)
0.01M-0.02M0.01M0.00M0.00M-0.03M0.04M0.02M-0.01M-0.01M0.00M-0.01M0.00M-0.01M0.01M0.02M-0.10M0.05M-0.08M0.04M
EBIT Growth (1y)
-51.09%-89.69%-74.31%-73.07%-61.11%-28.29%-0.49%41.45%14.35%6.89%-5.28%-81.36%-36.49%-42.62%-39.02%0.45%-67.34%-28.52%-47.14%-94.95%
EBIT Growth (3y)
-161.52%-53.11%-50.69%-26.47%-27.75%-31.34%-22.63%-22.49%-23.49%-19.43%-13.72%-1.87%-25.06%-19.50%-29.14%-52.11%
EBIT Growth (5y)
-83.68%-36.66%-38.02%-29.57%-36.63%-32.95%-30.41%-28.96%
EBIT Margin Growth (1y)
0.02M-0.02M0.00M0.00M-0.02M-0.02M0.01M0.03M0.02M0.04M0.01M-0.03M-0.02M-0.02M-0.01M0.03M-0.07M-0.01M-0.11M-0.09M
EBIT Margin Growth (3y)
-0.04M0.00M0.01M0.02M0.03M6.000.02M0.00M-0.02M0.00M0.01M0.03M-0.07M0.01M-0.11M-0.10M
EBIT Margin Growth (5y)
-0.04M0.02M0.01M0.02M-0.07M-0.03M-0.10M-0.07M
EBIT Margin (QoQ)
0.01M-0.02M0.01M0.00M0.00M-0.03M0.04M0.03M-0.01M-0.01M0.00M-0.01M0.00M-0.01M0.01M0.02M-0.10M0.05M-0.09M0.04M
EBIT (QoQ)
-9.78%-30.89%-12.62%-6.95%-2.19%-4.22%11.78%37.69%-49.49%-13.30%0.25%-7.34%-12.51%-18.40%2.77%23.13%-89.12%9.07%-11.31%-1.85%
EBT Growth (1y)
-56.39%-89.49%-75.73%-73.00%-57.85%-24.06%4.23%46.53%19.09%10.19%-1.71%-83.12%-32.16%-39.53%-36.02%3.94%-76.82%-33.62%-54.70%-110.30%
EBT Growth (3y)
-166.43%-51.98%-48.73%-23.12%-25.93%-28.29%-19.62%-19.21%-19.06%-15.84%-9.83%2.02%-23.65%-18.75%-28.87%-54.66%
EBT Growth (5y)
-82.46%-34.48%-35.41%-26.84%-36.08%-31.53%-29.21%-27.90%
EBT Margin Growth (1y)
0.02M-0.02M0.00M0.00M-0.01M-0.02M0.01M0.03M0.02M0.04M0.01M-0.03M-0.02M-0.02M-0.01M0.03M-0.07M-0.01M-0.11M-0.09M
EBT Margin Growth (3y)
-0.04M0.00M0.01M0.02M0.03M0.00M0.02M244.00-0.01M0.01M0.01M0.03M-0.07M0.01M-0.11M-0.09M
EBT Margin Growth (5y)
-0.04M0.03M0.01M0.02M-0.06M-0.03M-0.09M-0.06M
EBT Margin (QoQ)
0.01M-0.02M0.01M0.00M0.00M-0.03M0.04M0.02M-0.01M-0.01M0.00M-0.01M0.00M-0.01M0.01M0.02M-0.10M0.05M-0.08M0.04M
EBT (QoQ)
-10.35%-30.04%-12.95%-6.74%-0.68%-2.21%12.81%40.40%-52.33%-13.45%1.26%-7.31%-9.94%-19.78%3.74%24.22%-102.37%9.49%-11.45%-3.02%
EPS (Basic) Growth (1y)
-10.13%30.82%-52.02%-67.90%-38.28%-9.35%20.78%55.75%24.33%19.66%-0.30%-59.61%1.07%-12.97%10.82%27.44%-52.66%-3.47%-17.44%-55.55%
EPS (Basic) Growth (3y)
-10.73%38.37%40.06%-30.46%-4.84%15.30%-6.50%-5.84%-1.16%0.25%10.85%19.98%-4.55%2.07%-1.65%-21.68%
EPS (Basic) Growth (5y)
-0.33%26.64%28.06%-17.66%-11.72%6.61%-4.82%-6.00%
EPS (Basic) (QoQ)
-7.89%-35.26%-8.27%-6.26%11.14%-6.96%21.56%40.65%-51.96%-13.56%2.06%5.56%5.81%-29.68%22.69%23.16%-98.18%12.11%12.25%-1.77%
EPS (Diluted) Growth (1y)
40.56%25.24%33.60%-67.90%-38.28%-9.35%20.78%55.75%24.33%19.66%-0.30%-59.61%1.07%-12.97%10.82%27.44%-52.66%-3.47%-17.44%-55.55%
EPS (Diluted) Growth (3y)
-31.81%14.64%13.08%19.19%-5.84%-1.16%0.25%10.85%19.98%-4.55%2.07%-1.65%-21.68%
EPS (Diluted) Growth (5y)
-18.49%1.24%5.15%11.19%-6.00%
EPS (Diluted) (QoQ)
-7.89%-35.26%-8.27%-6.26%11.14%-6.96%21.56%40.65%-51.96%-13.56%2.06%5.56%5.81%-29.68%22.69%23.16%-98.18%12.11%12.25%-1.77%
FCF Margin Growth (1y)
-0.01M-0.01M-0.06M0.02M-0.02M-0.02M0.01M0.02M0.02M0.08M0.01M-0.03M-0.01M-0.05M-0.01M0.02M-0.04M-0.02M-0.08M-0.09M
FCF Margin Growth (3y)
0.01M-0.18M0.03M0.00M0.05M-0.04M0.01M0.00M0.00M0.01M0.02M-0.03M0.01M-0.08M-0.10M
FCF Margin Growth (5y)
0.04M-0.18M0.02M-0.06M-0.02M-0.13M-0.06M
FCF Margin (QoQ)
0.02M-0.01M0.00M0.02M-0.01M-0.01M0.02M0.03M-0.02M0.04M-0.04M-0.01M-933.000.00M0.00M0.02M-0.06M0.02M-0.06M0.01M
Free Cash Flow Growth (1y)FCF Growth (1y)
-307.59%-48.56%-739.42%-6.18%-56.19%-27.53%-10.04%45.25%12.34%159.49%11.62%-113.01%-2.14%-310.99%-44.02%-58.10%-34.97%-43.47%-12.99%-49.63%
Free Cash Flow Growth (3y)FCF Growth (3y)
-43.54%-48.11%-6.81%-77.38%46.23%-101.80%-7.39%-11.83%-16.98%-11.89%-22.63%-6.52%-21.66%-12.88%-71.44%
Free Cash Flow Growth (5y)FCF Growth (5y)
-29.99%-29.13%-32.63%-50.39%-27.82%-64.70%-23.98%
Free Cash Flow (QoQ)FCF (QoQ)
5.32%0.20%-45.10%22.56%-39.28%18.51%-25.19%61.46%-122.99%155.29%-286.01%7.12%-6.92%-14.22%-26.97%-1.96%8.72%-21.41%0.01%-35.02%
Net Cash Flow Growth (1y)NCF Growth (1y)
-138.28%54.21%-115.81%-160.24%114.82%125.28%-2,681.55%168.16%-376.51%-27.16%84.42%163.82%-6.56%-11.12%-607.96%-87.54%67.57%1,438.59%-415.73%-142.07%
Net Cash Flow Growth (3y)NCF Growth (3y)
44.12%-50.83%-37.28%-29.20%27.74%-38.99%2.70%24.14%29.34%-213.04%30.53%-43.51%115.16%-78.50%-28.83%
Net Cash Flow Growth (5y)NCF Growth (5y)
21.46%-29.04%-39.50%-15.49%25.82%-93.35%-15.51%
Net Cash Flow (QoQ)NCF (QoQ)
-165.75%-64.66%98.34%-3,252.57%116.17%180.89%-282.66%182.15%-165.60%173.99%-139.07%1,491.30%-126.50%161.72%-411.16%124.48%-168.97%3,028.27%-204.30%98.00%
Net Income Growth (1y)
-55.72%-89.32%-75.21%-72.09%-58.52%-23.91%4.23%46.53%19.09%10.19%-1.93%-83.49%-32.38%-39.55%-35.73%2.43%-76.53%-33.60%-54.70%-106.00%
Net Income Growth (3y)
-166.06%-51.19%-48.69%-73.28%-25.93%-28.20%-19.59%-19.08%-19.30%-15.80%-9.83%1.44%-23.65%-18.75%-28.87%-54.50%
Net Income Growth (5y)
-82.37%-34.06%-35.38%-50.55%-36.08%-31.47%-29.14%-27.68%
Net Income (QoQ)
-9.30%-30.75%-12.81%-6.74%-0.68%-2.21%12.81%40.40%-52.33%-13.45%1.04%-7.29%-9.90%-19.60%3.75%22.87%-98.83%9.49%-11.45%-2.71%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-55.72%-89.32%-75.21%-72.09%-58.52%-23.91%4.23%46.53%19.09%10.19%-1.93%-83.49%-32.38%-39.55%-35.73%2.43%-76.53%-33.60%-54.70%-106.00%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-166.06%-51.19%-48.69%-73.28%-25.93%-28.20%-19.59%-19.08%-19.30%-15.80%-9.83%1.44%-23.65%-18.75%-28.87%-54.50%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-82.37%-34.06%-35.38%-50.55%-36.08%-31.47%-29.14%-27.68%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-9.30%-30.75%-12.81%-6.74%-0.68%-2.21%12.81%40.40%-52.33%-13.45%1.04%-7.29%-9.90%-19.60%3.75%22.87%-98.83%9.49%-11.45%-2.71%
Net Margin Growth (1y)
0.02M-0.02M0.00M0.00M-0.01M-0.02M0.01M0.03M0.02M0.04M0.01M-0.03M-0.02M-0.02M-0.01M0.03M-0.07M-0.01M-0.11M-0.09M
Net Margin Growth (3y)
-0.04M0.00M0.01M-0.03M0.03M0.00M0.02M366.00-0.01M0.01M0.01M0.03M-0.07M0.01M-0.11M-0.09M
Net Margin Growth (5y)
-0.04M0.03M0.01M-0.03M-0.06M-0.03M-0.09M-0.06M
Net Margin (QoQ)
0.01M-0.02M0.01M0.00M0.00M-0.03M0.04M0.02M-0.01M-0.01M0.00M-0.01M0.00M-0.01M0.01M0.02M-0.10M0.05M-0.08M0.04M
Operating Income Growth (1y)Op. Inc Growth (1y)
-51.09%-89.69%-74.31%-73.07%-61.11%-28.29%-0.49%41.45%14.35%6.89%-5.28%-81.36%-36.49%-42.62%-39.02%0.45%-67.34%-28.52%-47.14%-94.95%
Operating Income Growth (3y)Op. Inc Growth (3y)
-161.52%-53.11%-50.69%-26.47%-27.75%-31.34%-22.63%-22.49%-23.49%-19.43%-13.72%-1.87%-25.06%-19.50%-29.14%-52.11%
Operating Income Growth (5y)Op. Inc Growth (5y)
-83.68%-36.66%-38.02%-29.57%-36.63%-32.95%-30.41%-28.96%
Operating Income (QoQ)Op. Inc (QoQ)
-9.78%-30.89%-12.62%-6.95%-2.19%-4.22%11.78%37.69%-49.49%-13.30%0.25%-7.34%-12.51%-18.40%2.77%23.13%-89.12%9.07%-11.31%-1.85%
Operating Margin Growth (1y)
0.02M-0.02M0.00M0.00M-0.02M-0.02M0.01M0.03M0.02M0.04M0.01M-0.03M-0.02M-0.02M-0.01M0.03M-0.07M-0.01M-0.11M-0.09M
Operating Margin Growth (3y)
-0.04M0.00M0.01M0.02M0.03M6.000.02M0.00M-0.02M0.00M0.01M0.03M-0.07M0.01M-0.11M-0.10M
Operating Margin Growth (5y)
-0.04M0.02M0.01M0.02M-0.07M-0.03M-0.10M-0.07M
Operating Margin (QoQ)
0.01M-0.02M0.01M0.00M0.00M-0.03M0.04M0.03M-0.01M-0.01M0.00M-0.01M0.00M-0.01M0.01M0.02M-0.10M0.05M-0.09M0.04M
Profit After Tax Growth (1y)PAT Growth (1y)
-55.72%-89.03%-75.21%-72.09%-58.52%-23.95%4.23%46.53%19.09%10.19%-1.93%-83.49%-32.38%-39.55%-35.73%2.43%-76.53%-33.60%-54.70%-106.00%
Profit After Tax Growth (3y)PAT Growth (3y)
-166.06%-51.19%-48.69%-73.28%-25.93%-28.15%-19.59%-19.08%-19.30%-15.82%-9.83%1.44%-23.65%-18.75%-28.87%-54.50%
Profit After Tax Growth (5y)PAT Growth (5y)
-82.37%-34.06%-35.38%-50.55%-36.08%-31.44%-29.14%-27.68%
Profit After Tax (QoQ)PAT (QoQ)
-9.30%-30.71%-12.85%-6.74%-0.68%-2.21%12.81%40.40%-52.33%-13.45%1.04%-7.29%-9.90%-19.60%3.75%22.87%-98.83%9.49%-11.45%-2.71%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
46.49%69.96%94.28%85.82%72.44%51.35%31.02%19.27%0.48%-2.07%0.87%0.34%2.94%5.65%3.23%1.16%20.09%26.65%17.61%6.57%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
64.28%36.41%36.07%36.93%30.53%21.28%16.12%10.91%6.58%7.50%9.43%6.99%2.65%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
35.62%25.70%27.51%25.53%19.11%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
14.67%18.51%19.24%14.68%6.41%4.01%3.23%4.39%-10.35%1.37%6.32%3.84%-8.02%4.03%3.90%1.76%9.19%9.72%-3.53%-7.79%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M0.00M0.00M0.00M-656.00-500.00-220.00207.00362.000.00M0.00M0.00M570.00-940.000.00M0.00M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M0.00M0.00M0.00M-856.00-283.00276.00-380.00-252.0079.000.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-18.00-450.00-546.00-751.00-301.00-103.00-421.00170.00-146.00177.006.00325.00552.00182.0028.00-191.00-958.0026.00-91.000.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-780.00321.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M0.00M0.00M0.00M0.00M-698.00159.00-812.00-501.0070.000.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-1.00-619.00-664.000.00M-292.00-186.00-598.00-129.00-182.00-418.00-52.00972.00863.00249.00121.00-190.000.00M124.00-26.000.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
423.000.00M0.00M0.00M0.00M0.00M0.00M-502.00-400.000.00M0.00M-221.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M-0.01M-0.01M0.00M0.00M0.00M43.00929.00-347.00-224.00389.000.00M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M0.00M0.00M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
96.00-695.00-913.000.00M-230.0042.00-599.00284.00-127.00-605.000.00M0.00M0.00M452.00148.00-330.000.00M166.0014.000.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.02M-0.02M0.00M0.00M-0.02M-0.02M0.01M0.03M0.02M0.04M0.01M-0.03M-0.02M-0.02M-0.01M0.03M-0.07M-0.01M-0.11M-0.09M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.04M0.00M0.01M0.02M0.03M6.000.02M0.00M-0.02M0.00M0.01M0.03M-0.07M0.01M-0.11M-0.10M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.04M0.02M0.01M0.02M-0.07M-0.03M-0.10M-0.07M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.01M-0.02M0.01M0.00M0.00M-0.03M0.04M0.03M-0.01M-0.01M0.00M-0.01M0.00M-0.01M0.01M0.02M-0.10M0.05M-0.09M0.04M
Revenue Growth (1y)
150.97%10.57%92.00%61.22%5.26%-8.29%31.85%168.33%71.13%123.49%30.74%-60.58%-31.84%-12.37%11.26%264.34%-37.29%2.21%-66.12%-79.47%
Revenue Growth (3y)
0.66%53.87%64.22%94.30%65.35%31.35%49.03%19.47%7.08%21.56%24.25%56.78%-9.90%26.03%-21.01%-33.45%
Revenue Growth (5y)
3.54%48.14%45.15%60.15%14.08%15.21%4.52%4.98%
Revenue (QoQ)
44.58%-27.86%30.08%18.82%-5.61%-37.14%87.01%141.83%-39.80%-17.91%9.41%-27.09%4.10%5.53%38.91%138.75%-82.08%71.99%-53.95%44.64%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
286.82%90.97%124.85%71.78%62.02%71.32%39.70%28.75%20.85%-3.29%-7.77%1.40%3.66%6.03%11.51%17.41%11.63%6.79%7.82%9.66%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
267.62%263.90%164.02%96.38%46.81%42.56%30.89%26.61%20.66%12.84%15.30%11.83%3.07%3.50%9.29%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
119.49%118.28%85.41%54.36%29.08%28.35%23.62%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
9.36%12.29%25.36%11.60%3.14%18.73%2.22%2.85%-3.19%-4.99%-2.52%13.08%-1.03%-2.81%2.52%19.07%-5.90%-7.02%3.50%21.10%

Nurix Therapeutics Growth Metrics API

Pull Nurix Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NRIX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY